Understanding the UK IPO option

  • Wednesday, 30 March 2022, 1:00 PM to 2:30 PM

This event will focus on Understanding the UK IPO option and will be an informal introduction to UK the listing process and environment, designed to help companies determine if it could be for them, when and critical steps to that target.

It will be presented by:

Tim Davis, Regional Head, UK Primary Markets, London Stock Exchange

Tim joined The London Stock Exchange in April 2019 and has responsibility for potential AIM and Main Market IPOs across The Midlands, Wales, East Anglia, Cambridge and Oxford.  In addition, he has national responsibility for all new Healthcare and related IPOs.

He spent the previous 20 years working in UK small and mid-cap advisory and broking at Teather & Greenwood, Charles Stanley Securities and Cantor Fitzgerald Europe.

Freddy Crossley, Panmure Gordon 

  • Over 20 years’ experience in corporate finance, ECM and M&A, Freddy leads Panmure Gordon’s healthcare investment banking team
  • Has led numerous M&A and equity market transactions on both AIM and the Main Market including Class 1 transactions, secondary fundraisings and IPOs, including the IPOs of Arecor, Dianomi, MaxCyte, Focusrite and Horizon Discovery.

Reserve your place

All occupiers are welcome to attend the event. Please email hugo.villanueva@stevenagecatalyst.com to reserve your place.


Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.